|1.||Swietaszczyk, Cyprian: 1 article (01/2012)|
|2.||Pilecki, Stanisław E: 1 article (01/2012)|
|3.||Cabrini, Romulo L: 1 article (09/2010)|
|4.||Oglio, Romina: 1 article (09/2010)|
|5.||Pisarev, Mario A: 1 article (09/2010)|
|6.||Thomasz, Lisa: 1 article (09/2010)|
|7.||Randi, Andrea S: 1 article (09/2010)|
|8.||Dagrosa, María A: 1 article (09/2010)|
|9.||Juvenal, Guillermo J: 1 article (09/2010)|
|10.||Fernandez, Marina: 1 article (09/2010)|
09/01/2010 - "The goiter inhibitory action of IL-delta is due to the inhibition of cell proliferation and the transient stimulation of apoptosis. "
10/01/1994 - "According to retention time (13.44 min) and specific fragments (m/z 303, m/z 259) the occurrence of IL-delta could be demonstrated in the extract of iodide treated goiter. "
06/02/1994 - "The thyroid gland synthesizes 6-delta-iodolactone, a compound shown to inhibit goiter growth in vivo and cell proliferation in culture. "
09/01/2010 - "The present studies were performed to test the hypotheses that IL-delta decreases thyroid growth by inhibition of cell proliferation and/or by stimulation of apoptosis due to oxidative stress, that TGF-beta is stimulated by an excess of iodide and by IL-delta, and that c-Myc and c-Fos expression are upregulated during goiter induction and downregulated during goiter inhibition. "
01/01/2012 - "One of the compounds, 6-iodo-5-hydroxy-eicosatrienoic acid delta-lactone (6-IL), is believed to inhibit goiter growth, to modulate the cell response on some growth factors, and to trigger apoptosis in some types of cells. "
|1.||Transforming Growth Factor beta (TGF-beta)
|2.||Intercellular Signaling Peptides and Proteins (Growth Factors)
|3.||Proliferating Cell Nuclear Antigen (PCNA)
|4.||Arachidonic Acid (Vitamin F)